FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: VOLUNTARY ANNOUNCEMENT IN RELATION TO THE 2025 H SHARE REPURCHASE PLAN AND THE 2025 A SHARE REPURCHASE PLAN
FOSUN PHARMA: Overseas Regulatory Announcement - Notice regarding the buyback plan of Listed in Hong Kong.
FOSUN PHARMA: Overseas regulatory announcement - Regarding the plan to repurchase A-shares through centralized competitive trading.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement of Resolutions from the Sixty-Eighth Meeting (Extraordinary Meeting) of the Ninth Board of Directors.
FOSUN PHARMA: Overseas regulatory announcement - Regarding the progress announcement of the absorption merger and privatization of the holding subsidiary HENLIUS Biotechnology Co., Ltd.
FOSUN PHARMA: JOINT ANNOUNCEMENT - (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING AND THE H SHAREHOLDERS' CLASS MEETING RELATING TO THE PROPOSED PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS AND (2) TERMINATION OF THE ME
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration of a Subsidiary
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration of a Subsidiary
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Progress of Drug Clinical Trial By a Subsidiary
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement Regarding Subsidiary's Approval for Pharmaceutical Clinical Trials
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Acceptance of a Subsidiary's Drug Registration Application
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Acceptance ofa Subsidiary's Drug Registration Application
FOSUN PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.